GB9927088D0 - Use of poly(diallylamine) polymers - Google Patents
Use of poly(diallylamine) polymersInfo
- Publication number
- GB9927088D0 GB9927088D0 GBGB9927088.6A GB9927088A GB9927088D0 GB 9927088 D0 GB9927088 D0 GB 9927088D0 GB 9927088 A GB9927088 A GB 9927088A GB 9927088 D0 GB9927088 D0 GB 9927088D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- polymer
- diallylamine
- poly
- nitrogen atoms
- diallyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 229920000642 polymer Polymers 0.000 title abstract 3
- -1 poly(diallylamine) Polymers 0.000 title abstract 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 abstract 1
- 239000003613 bile acid Substances 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 1
- 229920006037 cross link polymer Polymers 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/0605—Polycondensates containing five-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms
- C08G73/0611—Polycondensates containing five-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms with only one nitrogen atom in the ring, e.g. polypyrroles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G61/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G61/12—Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9927088.6A GB9927088D0 (en) | 1999-11-17 | 1999-11-17 | Use of poly(diallylamine) polymers |
| US10/130,246 US7767229B1 (en) | 1999-11-17 | 2000-11-10 | Use of poly diallyamine polymers |
| EP00974674A EP1265942B1 (en) | 1999-11-17 | 2000-11-10 | Use of poly(diallylamine) polymers |
| DE60017805T DE60017805T2 (de) | 1999-11-17 | 2000-11-10 | Verwendung von poly(diallylamin) polymeren |
| JP2001538997A JP2003514935A (ja) | 1999-11-17 | 2000-11-10 | ポリ（ジアリルアミン）ポリマー類の使用 |
| CA002391539A CA2391539C (en) | 1999-11-17 | 2000-11-10 | Use of poly(diallylamine) polymers |
| AU12893/01A AU772653B2 (en) | 1999-11-17 | 2000-11-10 | Use of poly(diallylamine) polymers |
| PCT/GB2000/004308 WO2001036510A2 (en) | 1999-11-17 | 2000-11-10 | Use of poly(diallylamine) polymers |
| AT00974674T ATE287911T1 (de) | 1999-11-17 | 2000-11-10 | Verwendung von poly(diallylamin) polymeren |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9927088.6A GB9927088D0 (en) | 1999-11-17 | 1999-11-17 | Use of poly(diallylamine) polymers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9927088D0 true GB9927088D0 (en) | 2000-01-12 |
Family
ID=10864611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9927088.6A Ceased GB9927088D0 (en) | 1999-11-17 | 1999-11-17 | Use of poly(diallylamine) polymers |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7767229B1 (https=) |
| EP (1) | EP1265942B1 (https=) |
| JP (1) | JP2003514935A (https=) |
| AT (1) | ATE287911T1 (https=) |
| AU (1) | AU772653B2 (https=) |
| CA (1) | CA2391539C (https=) |
| DE (1) | DE60017805T2 (https=) |
| GB (1) | GB9927088D0 (https=) |
| WO (1) | WO2001036510A2 (https=) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0606016D0 (en) * | 2006-03-25 | 2006-05-03 | Ionic Polymer Solutions Ltd | Quaternary ammonium compounds and their uses |
| GB0613013D0 (en) | 2006-06-30 | 2006-08-09 | Novel Polymer Solutions Ltd | Polymeric Materials and Methods for Manufacturing Them |
| DE102010002141A1 (de) | 2010-02-19 | 2011-08-25 | Momentive Performance Materials GmbH, 51373 | Integrale Bestrahlungseinheit |
| JP5986081B2 (ja) | 2010-08-02 | 2016-09-06 | シンター ファイン ケミカルズ リミテッド | 複合部材及びその製造方法 |
| WO2012017235A1 (en) | 2010-08-02 | 2012-02-09 | Novel Polymer Solutions Limited | Covered floors and methods of adhering flooring to a floor |
| WO2012017233A1 (en) | 2010-08-02 | 2012-02-09 | Novel Polymer Solutions Limited | Methods of coating a low surface energy substrate |
| PL3400944T3 (pl) | 2010-11-04 | 2020-11-16 | Albireo Ab | Inhibitory ibat w leczeniu chorób wątroby |
| GB201105453D0 (en) | 2011-03-31 | 2011-05-18 | Novel Polymer Solutions Ltd | Window frames, structural elements for a roofed construction and methods of assembling same |
| JP6228918B2 (ja) | 2011-08-18 | 2017-11-08 | モーメンテイブ・パーフオーマンス・マテリアルズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | 照射および成型ユニット |
| GB201115823D0 (en) | 2011-09-13 | 2011-10-26 | Novel Polymer Solutions Ltd | Mineral processing |
| HK1210740A1 (en) | 2012-06-11 | 2016-05-06 | 迈图高新材料集团 | Method for producing plastic compound molded bodies |
| SI3287133T1 (sl) | 2013-06-05 | 2019-09-30 | Tricida Inc. | Polimeri, ki vežejo protone,za peroralno dajanje |
| CA2952406A1 (en) | 2014-06-25 | 2015-12-30 | Ea Pharma Co., Ltd. | Solid formulation and method for preventing or reducing coloration thereof |
| LT3229816T (lt) | 2014-12-10 | 2020-05-25 | Tricida Inc. | Protoną prijungiantys polimerai, skirti peroraliniam įvedimui |
| US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
| US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| WO2017193024A1 (en) | 2016-05-06 | 2017-11-09 | Tricida, Inc. | Hcl-binding compositions for and method of treating acid-base disorders |
| JP2020530448A (ja) | 2017-08-09 | 2020-10-22 | アルビレオ・アクチボラグ | コレスチラミン顆粒、経口コレスチラミン製剤、及びそれらの使用 |
| US10934380B1 (en) | 2017-09-25 | 2021-03-02 | Tricida, Inc. | Crosslinked poly(allylamine) polymer pharmaceutical compositions |
| IL319146A (en) | 2017-11-03 | 2025-04-01 | Tricida Inc | Compositions for and method of treating acid-base disorders |
| ES2942443T3 (es) | 2018-06-05 | 2023-06-01 | Albireo Ab | Compuestos de benzotia(di)azepina y su uso como moduladores de ácidos biliares |
| US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| BR112020024479A2 (pt) | 2018-06-20 | 2021-03-02 | Albireo Ab | hidrato cristalino, modificações cristalinas de odevixibat, solvato misto de odevixibat, uso de modificação cristalina de odevixibat, processo para a preparação de modificação cristalina de odevixibat, e, composição farmacêutica |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
| HUE060905T2 (hu) | 2019-02-06 | 2023-04-28 | Albireo Ab | Benzotiadiazepin vegyületek és azok alkalmazása epesav modulátorként |
| CA3158181A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| CA3158184A1 (en) | 2019-12-04 | 2021-08-10 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| ES2973549T3 (es) | 2019-12-04 | 2024-06-20 | Albireo Ab | Compuestos de benzoti(di)azepina y su uso como moduladores de los ácidos biliares |
| CN114786772B (zh) | 2019-12-04 | 2024-04-09 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| EP4188541B1 (en) | 2020-08-03 | 2024-12-25 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
| JP2023549226A (ja) | 2020-11-12 | 2023-11-22 | アルビレオ エービー | 進行性家族性肝内胆汁うっ滞症（ｐｆｉｃ）を処置するためのオデビキシバット |
| JP2024500309A (ja) | 2020-12-04 | 2024-01-09 | アルビレオ エービー | ベンゾチア（ジ）アゼピン化合物および胆汁酸モジュレータとしてのその使用 |
| TW202313579A (zh) | 2021-06-03 | 2023-04-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE520401A (https=) * | 1952-06-03 | |||
| US3957699A (en) * | 1973-06-12 | 1976-05-18 | Ici Australia Limited | Process for polymerizing allylamines employing a redox initiator consisting of Fe++ or Ti+++ with H2 O2, hydroxyl amine, or hydroperoxides to form insoluble crosslinked polymers |
| US4121986A (en) * | 1975-05-07 | 1978-10-24 | Ici Australia Limited | Process for the polymerization of polyallylamines in the presence of a mineral acid solution |
| JPS5747302A (en) * | 1980-09-03 | 1982-03-18 | Mitsubishi Petrochem Co Ltd | Preparation of crosslinkable electrolytic polymer |
| JPS62257481A (ja) | 1986-04-30 | 1987-11-10 | 三洋化成工業株式会社 | 染料固着剤 |
| US4759923A (en) | 1987-06-25 | 1988-07-26 | Hercules Incorporated | Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives |
| JPH021358A (ja) * | 1988-03-01 | 1990-01-05 | Sanyo Chem Ind Ltd | インクジェット記録紙用薬剤 |
| US6203785B1 (en) | 1996-12-30 | 2001-03-20 | Geltex Pharmaceuticals, Inc. | Poly(diallylamine)-based bile acid sequestrants |
| US6083497A (en) * | 1997-11-05 | 2000-07-04 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
| US5985938A (en) * | 1997-11-05 | 1999-11-16 | Geltex Pharmaceuticals, Inc. | Method for reducing oxalate |
| US6726905B1 (en) | 1997-11-05 | 2004-04-27 | Genzyme Corporation | Poly (diallylamines)-based phosphate binders |
| SG105450A1 (en) * | 1998-07-02 | 2004-08-27 | Nat Starch Chem Invest | Allylated amide compounds and die attach adhesives prepared therefrom |
| SG85658A1 (en) * | 1998-07-02 | 2002-01-15 | Nat Starch Chem Invest | Package encapsulants prepared from allylated amide compounds |
| GB9816171D0 (en) * | 1998-07-25 | 1998-09-23 | Secr Defence | Monomers and network polymers obtained therefrom |
| GB9816167D0 (en) * | 1998-07-25 | 1998-09-23 | Secr Defence | Polymer production |
-
1999
- 1999-11-17 GB GBGB9927088.6A patent/GB9927088D0/en not_active Ceased
-
2000
- 2000-11-10 US US10/130,246 patent/US7767229B1/en not_active Expired - Fee Related
- 2000-11-10 JP JP2001538997A patent/JP2003514935A/ja active Pending
- 2000-11-10 AT AT00974674T patent/ATE287911T1/de not_active IP Right Cessation
- 2000-11-10 CA CA002391539A patent/CA2391539C/en not_active Expired - Fee Related
- 2000-11-10 WO PCT/GB2000/004308 patent/WO2001036510A2/en not_active Ceased
- 2000-11-10 DE DE60017805T patent/DE60017805T2/de not_active Expired - Lifetime
- 2000-11-10 AU AU12893/01A patent/AU772653B2/en not_active Ceased
- 2000-11-10 EP EP00974674A patent/EP1265942B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU1289301A (en) | 2001-05-30 |
| WO2001036510A2 (en) | 2001-05-25 |
| WO2001036510A3 (en) | 2002-09-12 |
| EP1265942B1 (en) | 2005-01-26 |
| US7767229B1 (en) | 2010-08-03 |
| JP2003514935A (ja) | 2003-04-22 |
| DE60017805T2 (de) | 2006-01-12 |
| AU772653B2 (en) | 2004-05-06 |
| DE60017805D1 (de) | 2005-03-03 |
| ATE287911T1 (de) | 2005-02-15 |
| EP1265942A2 (en) | 2002-12-18 |
| CA2391539C (en) | 2009-08-11 |
| CA2391539A1 (en) | 2001-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9927088D0 (en) | Use of poly(diallylamine) polymers | |
| AU2002217252A1 (en) | Cosmetic composition comprising a mixture of polymers | |
| AU2002230016A1 (en) | Cosmetic composition comprising a polymer and fibres | |
| AU2001285891A1 (en) | Use of hydrophilic graft copolymers with n-vinylamine and/or open-chained n-vinylamide units in cosmetic formulations | |
| EP0838487A3 (en) | Polyether copolymer and polymer solid electrolyte | |
| CA2395292A1 (en) | Organometal compound catalyst | |
| MY124377A (en) | Stable complexes of poorly soluble compounds | |
| BR0115813A (pt) | Polìmeros em forma de pente modificados por silìcio à base de ácido acriloil dimetiltaurìnico | |
| CA2384654A1 (en) | Organometal catalyst compositions | |
| NO20022631D0 (no) | Organometallforbindelse-katalysator | |
| EP1133989A3 (en) | Polymer compositions for use in therapy | |
| WO1995020610A3 (en) | Two-phase acidic aqueous compositions for diffusion transfer products | |
| BR0214136A (pt) | Polìmeros de enxerto, processo para a preparação e uso dos mesmos | |
| EP1370591A4 (en) | ACTIVE NON-METALLOCEN PRECATALYST AND METHOD FOR TACTICAL CATALYTIC POLYMERIZATION OF ALPHA-OLEFIN MONOMERS | |
| EP1995258A3 (en) | Catalyst composition for polymerizing monomers | |
| EP1103577A4 (en) | COPOLYMER SEQUENCE COMPOSITION, PROCESS FOR PRODUCING THE SAME, AND PRESSURE SENSITIVE ADHESIVE COMPOSITION THUS OBTAINED | |
| EP0835888A3 (de) | Unvernetztes Anion-Austauscherharz und diesen enthaltende pharmazeutische Zusammensetzung | |
| MXPA03009568A (es) | Metodo para reducir el nivel de glucosa en el suero. | |
| WO2003059382A3 (en) | Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression | |
| BR0212169A (pt) | Composição polimérica, processos para a preparação da mesma e de um derivado de poliisobuteno, e, derivado de poliisobuteno | |
| WO2003018647A1 (en) | Propylene polymer | |
| CA2127926A1 (en) | Higher .alpha.-olefin copolymer, process for the preparation of the same, rubber composition comprising the same, and rubber molded product comprising the same | |
| TW367335B (en) | Cyclo-olefin polymers and preparation process thereof | |
| CA2359494A1 (en) | Polymer compositions for intraluminal stent | |
| BR0015142A (pt) | Métodos para a preparação de composições biodegradáveis macias e elásticas de copolìmero de polihidroxialcanoato e produtos poliméricos compreendendo estas composições |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |